The FDA Biologics Effectiveness and Safety (BEST) Initiative
The U.S. Food & Drug Administration (FDA) needs to make decisions on drug and vaccine safety and effectiveness with confidence. As a key collaborator, Optum Epidemiology generates reproducible results that inform decisions for COVID-19 vaccines. Learn more at bestinitiative.org.
Related healthcare insights
Article
Discover insights from Dr. John Seeger’s recent participation at the Duke-Margolis Thirteenth Annual Sentinel Initiative Public Workshop.
Article
See how the FDA and Optum use real-world evidence to monitor the safety and effectiveness of COVID-19 vaccines in our youngest populations.
E-book
Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.